Healthcare provider profile · identity verified

Kevin Chen, NP-C

Nurse Practitioner · CHICAGO, IL · NPI 1700462074

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	393	42
Levothyroxine Sodium	Levothyroxine Sodium	287	31
Donepezil Hcl	Donepezil Hcl	280	33
Amlodipine Besylate	Amlodipine Besylate	225	26
Gabapentin	Gabapentin	219	22
Quetiapine Fumarate	Quetiapine Fumarate	217	23
Losartan Potassium	Losartan Potassium	205	21
Metoprolol Succinate	Metoprolol Succinate	201	21
Lisinopril	Lisinopril	188	21
Sertraline Hcl	Sertraline Hcl	182	24
Eliquis	Apixaban	181	25
Pantoprazole Sodium	Pantoprazole Sodium	161	18
Tamsulosin Hcl	Tamsulosin Hcl	160	17
Furosemide	Furosemide	154	25
Escitalopram Oxalate	Escitalopram Oxalate	148	16
Trazodone Hcl	Trazodone Hcl	131	25
Mirtazapine	Mirtazapine	130	19
Memantine Hcl	Memantine Hcl	128	18
Omeprazole	Omeprazole	124	17
Potassium Chloride	Potassium Chloride	107	14
Myrbetriq	Mirabegron	87	12
Carvedilol	Carvedilol	86	suppressed
Spironolactone	Spironolactone	83	12
Tizanidine Hcl	Tizanidine Hcl	80	18
Warfarin Sodium	Warfarin Sodium	80	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	77	11
Carbidopa-Levodopa	Carbidopa/Levodopa	76	suppressed
Metformin Hcl	Metformin Hcl	75	suppressed
Aripiprazole	Aripiprazole	69	suppressed
Clopidogrel	Clopidogrel Bisulfate	69	suppressed
Duloxetine Hcl	Duloxetine Hcl	69	11
Montelukast Sodium	Montelukast Sodium	68	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	67	11
Cefpodoxime Proxetil	Cefpodoxime Proxetil	66	41
Finasteride	Finasteride	66	suppressed
Famotidine	Famotidine	61	suppressed
Lorazepam	Lorazepam	61	22
Citalopram Hbr	Citalopram Hydrobromide	58	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	49	suppressed
Memantine Hcl Er	Memantine Hcl	49	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	48	suppressed
Risperidone	Risperidone	47	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	44	suppressed
Propranolol Hcl	Propranolol Hcl	43	suppressed
Alendronate Sodium	Alendronate Sodium	41	suppressed
Simvastatin	Simvastatin	41	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	39	suppressed
Buspirone Hcl	Buspirone Hcl	38	suppressed
Nifedipine Er	Nifedipine	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	16
Levetiracetam	Levetiracetam	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	12
Allopurinol	Allopurinol	35	suppressed
Cephalexin	Cephalexin	35	17
Clonazepam	Clonazepam	33	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Bumetanide	Bumetanide	30	suppressed
Chlorthalidone	Chlorthalidone	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	16
Prednisone	Prednisone	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Divalproex Sodium	Divalproex Sodium	27	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Nystop	Nystatin	27	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Loperamide	Loperamide Hcl	26	18
Jardiance	Empagliflozin	25	suppressed
Methimazole	Methimazole	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Trimethoprim	Trimethoprim	23	suppressed
Olanzapine	Olanzapine	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Ramipril	Ramipril	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Colchicine	Colchicine	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	12
Glipizide Er	Glipizide	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Bimatoprost	Bimatoprost	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Nystatin	Nystatin	16	suppressed
Azithromycin	Azithromycin	15	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	15	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Amoxicillin	Amoxicillin	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	13	suppressed
Digoxin	Digoxin	13	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Qulipta	Atogepant	13	suppressed
Valsartan	Valsartan	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Levetiracetam Er	Levetiracetam	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Mirabegron Er	Mirabegron	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Ozempic	Semaglutide	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error